InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.92
(
-0.06%
)
Bitcoin
68,544.47
(
-1.05%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lakeshore555

Send PM Follow Ignore
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

lakeshore555

Re: A deleted message

Monday, 01/27/2014 10:19:33 AM

Monday, January 27, 2014 10:19:33 AM

Post# of 30046
Radient does not make or sell drugs. Radient does not make or sell a lung cancer test.

The real competition for Radient's test is the Circulating Tumor Cell (CTC) Test from Veridex (Johnson & Johnson).

http://www.investor.jnj.com/releasedetail.cfm?releaseid=754133

it's already available for monitoring breast cancer:

https://veridex.com/CellSearch/Patients/FAQ.aspx

Johnson & Johnson is a Pharma SuperPower with lobbyists and political clout. Let's say for the sake of discussion that in five years, JNJ and Radient are both selling a blood test to screen for cancer. If the two tests are identical in specificity and sensitivity, JNJ wins, Radient loses.

And JNJ's test sounds like it will have higher specificity and sensitivity. Bad news for Radient.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up